Subscribe To
ADAG / Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
ADAG News
By Zacks Investment Research
September 27, 2023
Is Adagene (ADAG) Outperforming Other Medical Stocks This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and AN2 Therapeutics, Inc. (ANTX) have performed compared to their sector so far this year. more_horizontal
By Zacks Investment Research
May 25, 2023
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and The Cooper Companies (COO) have performed compared to their sector so far this year. more_horizontal
By Benzinga
March 16, 2022
Adagene Shares Pop After FDA Clears Phase 1b/2 Trial For ADG126/Keytruda Combo Therapy In Solid Tumors
The FDA has cleared Adagene Inc's (NASDAQ: ADAG) Phase 1b/2 clinical trial of its anti-CTLA-4 monoclonal antibody (mAb), ADG126, in combination wit more_horizontal